Article

Millipore Strengthens Bioprocess Division with Serologicals Acquistion

Millipore Corporation (Billerica, MA, www.millipore.com) and Serologicals Corporation (Norcross, GA, www.serologicals.com) have announced an agreement in which Millipore will acquire Serologicals in a cash transaction valued at approximately $1.4 billion and set to close by June 30, 2006.

Millipore Corporation (Billerica, MA, www.millipore.com) and Serologicals Corporation (Norcross, GA, www.serologicals.com) have announced an agreement in which Millipore will acquire Serologicals in a cash transaction valued at approximately $1.4 billion. The deal is set to close by June 30, 2006.

The agreement strengthens Millipore’s workforce to 5800 employees and builds its projected combined annual revenue to $1.4 billion.

Serologicals provides biological products, technologies, and services and maintains operations in both bioprocessing and research. The acquisition will boost Millipore’s Bioprocess Division in various growth segments, including drug discovery, antibodies, cell biology reagents, and stem cell research. The company also gains a cell-culture supplements offering, thereby facilitating entry into the $1-billion upstream bioprocessing market. The move reportedly makes Millipore the only company in the life sciences industry with both upstream cell-culture and downstream separation offerings for biopharmaceutical production.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content